Intervene Immune, Inc. — Form D

Intervene Immune, Inc. of MANHATTAN BEACH, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-12-27. $471K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2019-12-27
• Form: D
• Accession: 0001797564-19-000001
• Industry: Biotechnology
• Exemptions: 04, 06b, 4a5
• Amount sold: $471K
• Investors: 6
• Date of first sale: 2013-11-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-356563

Issuer

• Name: Intervene Immune, Inc.
• CIK: 0001797564
• Entity type: Corporation
• Jurisdiction: NEVADA
• Address: 1601 N. SEPULVEDA BOULEVARD, MANHATTAN BEACH, CA, 90266
• Phone: (513) 341-5412

Officers, directors & promoters (7)

More

• CIK 1797564 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search